RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL
Status:
RECRUITING
Trial end date:
2030-06-30
Target enrollment:
Participant gender:
Summary
This is a prospective, single-arm, multicenter clinical study to evaluate the efficacy and safety of chidamide, rituximab combined with lenalidomide sequential immunochemotherapy in the treatment of newly diagnosed elderly double-expressor diffuse large B-cell lymphoma.